Ocular Therapeutix
OCUL
$5.87
Share price
16.93%
Change (1 day)
-5.02%
Change (1 year)
Categories
EPS for Ocular Therapeutix (OCUL)
EPS in 2023 (TTM): -$1.16
According to Ocular Therapeutix's latest financial reports the company's current EPS (TTM) is -$1.16. In 2022 the company made an earnings per share (EPS) of -$0.91 a decrease over its 2021 EPS that were of -$0.09000.
EPS history for Ocular Therapeutix from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.16 | 27.47% |
| 2022 | -$0.91 | 911.11% |
| 2021 | -$0.09000 | -96.33% |
| 2020 | -$2.45 | 28.27% |
| 2019 | -$1.91 | 21.66% |
| 2018 | -$1.57 | -28.64% |
| 2017 | -$2.20 | 21.55% |
| 2016 | -$1.81 | 6.47% |
| 2015 | -$1.70 | -68.52% |
| 2014 | -$5.40 | 38.73% |
| 2013 | -$3.89 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | -$1.65 | 42.24% | 🇺🇸 USA |
 Anika Therapeutics ANIK | -$1.53 | 31.90% | 🇺🇸 USA |
 Intersect ENT XENT | -$2.22 | 91.38% | 🇺🇸 USA |
 Haemonetics HAE | $2.53 | -318.40% | 🇺🇸 USA |